Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 435

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 435
---
 in the aggregate amount of up to $157,143 which was made available in Argentine Pesos, and is available for disbursement through September 1, 2024. The outstanding balance of this loan as of June 30, 2024 was $22,118. On April 18, 2024 the maturity of this agreement was extended to September 1, 2028 and accrues interest at 6.5% per annum. On January 17, 2023, Heritas Argentina and CIBIC entered into a revolving loan agreement in the aggregate amount of up to $1,006,686, which was made available in Argentine Pesos, for working capital and general corporate purposes, and is available for disbursement through January 17, 2024. On January 31, 2023, the parties executed an amendment to adjust certain commercial conditions. On October 23, 2023, the parties executed an amendment to increase the facility amount to up to $1,106,686. The outstanding balance of this loan as of June 30, 2024 was $127,190. On April 18, 2024 the maturity of this agreement was extended to January 17, 2028 and accrues interest at 6.5% per annum. On October 1, 2023, Heritas Argentina and CIBIC entered into a revolving loan agreement in the aggregate amount of up to $238,742, which was made available in Argentine Pesos, and is available for disbursement through October 1, 2024. The outstanding balance of this loan as of June 30, 2024 was $0.01. On March 20, 2024 the maturity of this agreement was extended to October 1, 2028 and accrues interest at 6.5% per annum. Subsequent Events Loan Amendments and Credit Line Extensions In connection with the credit agreements with CIBIC and Bioceres described in note 20 to Omnigenics unaudited interim condensed combined financial statements as of December31, 2024, and to support ongoing operations, the subsidiary Heritas S.A.U. received financing from these credit facilities after December31, 2024, totaling $178,006: •$81,996 of financing from Bioceres S.A. On March18, 2025, Heritas Argentina amended its existing loans agreements with Bioceres S.A. to extend the two available credit lines from a total of